An Osimertinib-Perfluorocarbon Nanoemulsion with Excellent Targeted Therapeutic Efficacy in Non-small Cell Lung Cancer: Achieving Intratracheal and Intravenous Administration-Reference-Cited by-同舟云学术

An Osimertinib-Perfluorocarbon Nanoemulsion with Excellent Targeted Therapeutic Efficacy in Non-small Cell Lung Cancer: Achieving Intratracheal and Intravenous Administration

Published:2022-07-21 Issue:8 Volume:16 Page:12590-12605
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Yang Jie¹²^ORCID,Li Yingbo¹²^ORCID,Sun Jiemei¹²,Zou Hongyan¹²,Sun Yige¹²,Luo Jing¹²,Xie Qian¹²,A Rong¹²^ORCID,Wang Hongbin¹²,Li Xiaona¹²,Wang Kai¹²,Yang Lili¹²,Ma Teng³,Wu Lina¹²,Sun Xilin¹²^ORCID

Affiliation:

1. NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Molecular Imaging Research Center (MIRC), Harbin Medical University, 150028 Harbin, Heilongjiang, China

2. Department of Nuclear Medicine, the Fourth Hospital of Harbin Medical University, 150028 Harbin, Heilongjiang, China

3. Shenzhen Key Laboratory of Ultrasound Imaging and Therapy, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 518055 Shenzhen, Guangdong, China

Funder

Ministry of Science and Technology of the People's Republic of China

Natural Science Foundation of Heilongjiang Province

Harbin Medical University

China Scholarship Council

National Natural Science Foundation of China

Heilongjiang Province

National Reform and Development Funds for Local Universities

Heilongjiang Provincial Key Laboratory of Molecular Imaging foundation

Publisher

American Chemical Society (ACS)

Subject